Susquehanna International Group
SNOA icon

Susquehanna International Group’s Sonoma Pharmaceuticals SNOA Stock Holding History

Susquehanna International Group’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,303
Closed -$7.66K – 13157
2024
Q1 		$7.66K Buy
+2,303
New +$7.43K ﹤0.01% 11930
2018
Q4 		– Sell
-252
Closed -$66K – 9890
2018
Q3 		$66K Buy
+252
New +$91.6K ﹤0.01% 8760
2016
Q4 		– Sell
-60
Closed -$47K – 10107
2016
Q3 		$47K Buy
+60
New +$45.1K ﹤0.01% 8138

Other funds holding SNOA

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group's SNOA Position: Q2 2024 in Review

Susquehanna International Group sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2024, closing a stake of 2,303 shares — an estimated $7.66K sold.

Susquehanna International Group first reported a position in SNOA in Q3 2016 and held it in 3 quarters. The position peaked at $66K in Q3 2018. 17 funds tracked by Wall St. Rank hold SNOA as of Q2 2024.

  • Susquehanna International Group reported no remaining Sonoma Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 2,303 Sonoma Pharmaceuticals shares in Q2 2024, an estimated $7.66K.
  • Susquehanna International Group first reported a position in Sonoma Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • Susquehanna International Group's Sonoma Pharmaceuticals position peaked at $66K in Q3 2018.
  • 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.